Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

Yuehui Zhao, Naveen Ramesh, Ping Xu, Emi Sei, Min Hu, Shanshan Bai, Patricia Troncoso, Ana M. Aparicio, Christopher J. Logothetis, Paul G. Corn, Nicholas E. Navin, Amado J. Zurita

Cancer Res (2025) 85 (9): 1680–1695.

https://doi.org/10.1158/0008-5472.CAN-24-1943

Published: 02 May 2025

View articletitled, Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

Includes: Supplementary data

Journal Articles

Abstract CT132: Phase 2 trial of metastasis directed radiotherapy without systemic therapy (MRWS) for oligometastatic clear cell renal cell carcinoma (ccRCC) and investigation of circulating tumor DNA (ctDNA) as a personalized biomarker

Cancer Res (2025) 85 (8_Supplement_2): CT132.

https://doi.org/10.1158/1538-7445.AM2025-CT132

Published: 25 April 2025

View articletitled, Abstract CT132: Phase 2 trial of metastasis directed radiotherapy without systemic therapy (MRWS) for oligometastatic clear cell renal cell carcinoma (ccRCC) and investigation of circulating tumor DNA (ctDNA) as a personalized biomarker

Journal Articles

Abstract 3791: Investigating longitudinal therapeutic resistance in serially treated metastatic castration resistant prostate cancer by liquid biopsy genome sequencing

Yuehui Zhao, Naveen Ramesh, Emi Sei, Min Hu, Shanshan Bai, Patricia Troncoso, Paul Corn, Ana Aparicio, Christopher J. Logothetis, Nicholas E. Navin, Amado J. Zurita

Cancer Res (2022) 82 (12_Supplement): 3791.

https://doi.org/10.1158/1538-7445.AM2022-3791

Published: 15 June 2022

View articletitled, Abstract 3791: Investigating longitudinal therapeutic resistance in serially treated metastatic castration resistant prostate cancer by liquid biopsy genome sequencing

Journal Articles

Abstract 446: Plasma genome sequencing identifies prostate cancer patients that are sensitive to platinum-based therapy

Naveen Ramesh, Emi Sei, Pei Ching Tsai, Christopher Logothetis, Paul Corn, Ana Aparicio, Amado J. Zurita, Nicholas E. Navin

Cancer Res (2019) 79 (13_Supplement): 446.

https://doi.org/10.1158/1538-7445.AM2019-446

Published: 01 July 2019

View articletitled, Abstract 446: Plasma genome sequencing identifies prostate cancer patients that are sensitive to platinum-based therapy

Journal Articles

Abstract 3665: Longitudinal monitoring of prostate cancer evolution by plasma genome sequencing

Naveen Ramesh, Emi Sei, Ruli Gao, Pei Ching Tsai, Christopher Logothetis, Amado J. Zurita, Nicholas E. Navin

Cancer Res (2018) 78 (13_Supplement): 3665.

https://doi.org/10.1158/1538-7445.AM2018-3665

Published: 01 July 2018

View articletitled, Abstract 3665: Longitudinal monitoring of prostate cancer evolution by plasma genome sequencing

Journal Articles

Abstract 4966: High-definition single cell analysis (HD-SCA) reveals enrichment in androgen receptor (AR) expression in tumor cell clusters in bone marrow and blood of metastatic castration-resistant prostate cancer (mCRPC) patients

Amado J. Zurita, Anders Carlsson, Patricia Troncoso, James Hicks, Christopher J. Logothetis, Peter Kuhn

Cancer Res (2016) 76 (14_Supplement): 4966.

https://doi.org/10.1158/1538-7445.AM2016-4966

Published: 15 July 2016

View articletitled, Abstract 4966: High-definition single cell analysis (HD-SCA) reveals enrichment in androgen receptor (AR) expression in tumor cell clusters in bone marrow and blood of metastatic castration-resistant prostate cancer (mCRPC) patients

Journal Articles

Abstract 29: Myeloid cell and plasma cytokine and angiogenic factor (CAF) dynamics in association with response to VEGFR inhibitors cediranib and sunitinib

Alper Yetil, John V. Heymach, Amado J. Zurita

Cancer Res (2014) 74 (19_Supplement): 29.

https://doi.org/10.1158/1538-7445.AM2014-29

Published: 01 October 2014

View articletitled, Abstract 29: Myeloid cell and plasma cytokine and angiogenic factor (CAF) dynamics in association with response to VEGFR inhibitors cediranib and sunitinib

Journal Articles

Abstract 4645: Plasma cytokine and angiogenic factor (CAF) profiling for identification of markers associated with clinical benefit from bevacizumab (BEV) and with primary tumor presence in a phase II presurgical study of metastatic renal cell carcinoma (mRCC) patients

Alper Yetil, Eric Jonasch, Xuemei Wang, Christopher Wood, Surena Matin, Hai T. Tran, Nizar M. Tannir, John V. Heymach, Amado J. Zurita

Cancer Res (2013) 73 (8_Supplement): 4645.

https://doi.org/10.1158/1538-7445.AM2013-4645

Published: 15 April 2013

View articletitled, Abstract 4645: Plasma cytokine and angiogenic factor (CAF) profiling for identification of markers associated with clinical benefit from bevacizumab (BEV) and with primary tumor presence in a phase II presurgical study of metastatic renal cell carcinoma (mRCC) patients

Journal Articles

Abstract 2903: Therapeutic targeting of leukemia and lymphoma with a neuropilin-1 binding pro-apoptotic peptide

Katja Karjalainen, Diana E. Jaalouk, Carlos E. Bueso-Ramos, Amado J. Zurita, Akihiko Kuniyasu, Bedrich L. Eckhardt, Frank C. Marini, Benjamin Lichtiger, Susan O'Brien, Hagob M. Kantarjian, Jorge E. Cortes, Erkki Koivunen, Wadih Arap, Renata Pasqualini

Cancer Res (2012) 72 (8_Supplement): 2903.

https://doi.org/10.1158/1538-7445.AM2012-2903

Published: 15 April 2012

View articletitled, Abstract 2903: Therapeutic targeting of leukemia and lymphoma with a neuropilin-1 binding pro-apoptotic peptide

Journal Articles

Abstract #LB-268: Circulating endothelial cells (CEC) and progenitors (CEP) and VEGFR-1-expressing monocytes as biomarkers for patients (pts) with renal cell carcinoma (RCC)

Hua-Kang Wu, Eric Jonasch, Christopher Wood, Nizar M. Tannir, Surena Matin, Kathryn S. McKee, John V. Heymach, Amado J. Zurita

Cancer Res (2009) 69 (9_Supplement): LB-268.

Published: 01 May 2009

View articletitled, Abstract #LB-268: Circulating endothelial cells (CEC) and progenitors (CEP) and VEGFR-1-expressing monocytes as biomarkers for patients (pts) with renal cell carcinoma (RCC)

Journal Articles

Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries

Mikhail G. Kolonin, Laura Bover, Jessica Sun, Amado J. Zurita, Kim-Anh Do, Johanna Lahdenranta, Marina Cardó-Vila, Ricardo J. Giordano, Diana E. Jaalouk, Michael G. Ozawa, Catherine A. Moya, Glauco R. Souza, Fernanda I. Staquicini, Akihiko Kunyiasu, Dominic A. Scudiero, Susan L. Holbeck, Edward A. Sausville, Wadih Arap, Renata Pasqualini

Cancer Res (2006) 66 (1): 34–40.

https://doi.org/10.1158/0008-5472.CAN-05-2748

Published: 05 January 2006

View articletitled, Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries

Includes: Supplementary data

Journal Articles

Combinatorial Screenings in Patients: The Interleukin-11 Receptor α as a Candidate Target in the Progression of Human Prostate Cancer

Amado J. Zurita, Patricia Troncoso, Marina Cardó-Vila, Christopher J. Logothetis, Renata Pasqualini, Wadih Arap

Cancer Res (2004) 64 (2): 435–439.

https://doi.org/10.1158/0008-5472.CAN-03-2675

Published: 26 January 2004

View articletitled, Combinatorial Screenings in Patients: The Interleukin-11 Receptor α as a Candidate Target in the Progression of Human Prostate Cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

Abstract CT132: Phase 2 trial of metastasis directed radiotherapy without systemic therapy (MRWS) for oligometastatic clear cell renal cell carcinoma (ccRCC) and investigation of circulating tumor DNA (ctDNA) as a personalized biomarker

Abstract 3791: Investigating longitudinal therapeutic resistance in serially treated metastatic castration resistant prostate cancer by liquid biopsy genome sequencing

Abstract 446: Plasma genome sequencing identifies prostate cancer patients that are sensitive to platinum-based therapy

Abstract 3665: Longitudinal monitoring of prostate cancer evolution by plasma genome sequencing

Abstract 4966: High-definition single cell analysis (HD-SCA) reveals enrichment in androgen receptor (AR) expression in tumor cell clusters in bone marrow and blood of metastatic castration-resistant prostate cancer (mCRPC) patients

Abstract 29: Myeloid cell and plasma cytokine and angiogenic factor (CAF) dynamics in association with response to VEGFR inhibitors cediranib and sunitinib

Abstract 4645: Plasma cytokine and angiogenic factor (CAF) profiling for identification of markers associated with clinical benefit from bevacizumab (BEV) and with primary tumor presence in a phase II presurgical study of metastatic renal cell carcinoma (mRCC) patients

Abstract 2903: Therapeutic targeting of leukemia and lymphoma with a neuropilin-1 binding pro-apoptotic peptide

Abstract #LB-268: Circulating endothelial cells (CEC) and progenitors (CEP) and VEGFR-1-expressing monocytes as biomarkers for patients (pts) with renal cell carcinoma (RCC)

Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries

Combinatorial Screenings in Patients: The Interleukin-11 Receptor α as a Candidate Target in the Progression of Human Prostate Cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only